A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management
Authors:
- Abdelmalek MouazerAMAbdelmalek Mouazer
- Sophie DuboisSDSophie Dubois
- Romain LéguillonRLRomain Léguillon
- Nada BoudegzdameNBNada Boudegzdame
- Thibaud LevrardTLThibaud Levrard
- Yoann Le BarsYBYoann Le Bars
- Christian SimonCSChristian Simon
- Brigitte SéroussiBSBrigitte Séroussi
- Julien GrosjeanJGJulien Grosjean
- Romain LelongRLRomain Lelong
- Catherine LetordCLCatherine Letord
- Stéfan DarmoniSDStéfan Darmoni
Preprint
Abstract
Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines and on the visual presentation of aggregated drug knowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial, each pharmacist performing a medication review for two fictitious patients without ABiMed, and two others with ABiMed. We recorded the problems identified by the pharmacists, the interventions proposed, the response time, the perceived usability and the comments. Pharmacists' medication reviews were compared to an expert-designed gold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant drug-related problems during the medication review (p=1.1e-12) and proposed better interventions (p=9.8e-9), without needing more time (p=0.56). The System Usability Scale score is 82.7, which is ranked "excellent". In their comments, pharmacists appreciated the visual aspect of ABiMed and its ability to compare the current treatment with the proposed one. A multifactor analysis showed no difference in the support offered by ABiMed according to the pharmacist's age or sex, in terms of percentage of problems identified or quality of the proposed interventions. Conclusions: The use of an intelligent and visual clinical decision support system can help pharmacists when they perform medication reviews. Our main perspective is the validation of the system in clinical conditions.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- STOPP/START criteria for potentially inappropriate prescribing in older people: version 3European Geriatric Medicine, 2023
- Decision-support systems for managing polypharmacy in the elderly: A scoping reviewJournal of Biomedical Informatics, 2022
- Medication review and reconciliation in older adultsEuropean Geriatric Medicine, 2021
- Reducing Inappropriate Drug Use in Older Patients by Use of Clinical Decision Support in Community Pharmacy: A Mixed-Methods EvaluationDrugs & Aging, 2019
- PCNE definition of medication review: reaching agreementInternational Journal of Clinical Pharmacy, 2018
- Polimedication: applicability of a computer tool to reduce polypharmacy in nursing homesInternational Psychogeriatrics, 2018
- Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patientsThe European Journal of Health Economics, 2016
- Potential drug-related problems detected by electronic expert support system: physicians’ views on clinical relevanceInternational Journal of Clinical Pharmacy, 2015
- Automation bias: Empirical results assessing influencing factorsInternational Journal of Medical Informatics, 2014
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology, 2012